DOT Drug Test
A federally regulated urine drug test following strict 49 CFR Part 40 procedures, required for safety-sensitive employees in DOT-regulated industries.
Key Facts
- Standard 5-panel: marijuana, cocaine, amphetamines, opioids, PCP
- Oral fluid testing approved by DOT since June 2023
- MRO reviews all non-negative results before reporting
- Chain of custody required from collection to reporting
- Pre-employment test must be negative before safety-sensitive work
DOT drug testing follows precise chain-of-custody procedures mandated by 49 CFR Part 40. The standard DOT panel tests for five drug classes: marijuana (THC), cocaine, amphetamines/methamphetamines, opioids (codeine, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, 6-AM/heroin), and PCP. Testing is required pre-employment, randomly, post-accident, upon reasonable suspicion, return-to-duty, and for follow-up. All specimens must be analyzed by SAMHSA-certified laboratories and results reviewed by a Medical Review Officer (MRO).
Drug Testing Methods Compared
Side-by-side comparison of common workplace drug testing approaches.
| Type | Panel Size | Detection Window | Specimen | DOT Approved |
|---|---|---|---|---|
| DOT 5-Panel | 5 substances | 1–3 days | Urine or oral fluid | Yes |
| Non-DOT Panel | 5–17+ substances | 1–3 days | Urine | N/A |
| Hair Follicle | 5–17+ substances | Up to 90 days | Hair | No |
| Oral Fluid | 5–12+ substances | 24–48 hours | Saliva | Yes (since 2023) |
Related Services
Related Industries
Simplify Your Compliance
BlueHive manages occupational health services so you can focus on your workforce.